Consistently, DCM hearts were characterized by a significant increase of both NFκB levels and two NFκB target gene products (i.e., miR-146a and miR-146b), which exert negative feedback on the axis (Figure 3F–G and Figure S2) [26]. The gene discussed is NFKB1; the disease is familial dilated cardiomyopathy.